Quarterly Result11 Feb 2026, 06:22 pm
IOL Chemicals & Pharmaceuticals Reports Q3 & 9M FY26 Results: PBT Up 39% YoY, Margin Expansion
AI Summary
IOL Chemicals & Pharmaceuticals Ltd., one of the leading Active Pharmaceutical Ingredient (API) manufacturers, announced its Financial Results for the quarter and nine months ended 31st December 2025. The company reported a 39% YoY increase in profit before exceptional items and tax (PBT) in Q3 FY26, alongside margin expansion across all key financial metrics. The Pharmaceuticals segment led the growth with an 18% revenue increase YoY, and the Chemicals segment achieved optimal capacity utilization with a 37% YoY increase in EBIT.
Key Highlights
- PBT for Q3 FY26 increased by 39% YoY
- Margin expansion across all key financial metrics
- Pharmaceuticals segment reported an 18% revenue increase YoY
- Chemicals segment achieved optimal capacity utilization
- 37% YoY increase in EBIT for the Chemicals segment